Study: Anti-psychotics raise mortality in older Alzheimer's patients

01/8/2009 | Google

U.K. researchers found that 46% of Alzheimer's patients who were treated with psychiatric drugs, including Risperdal and Thorazine, were alive after two years, compared with 71% of those who took placebo. The study was conducted from 2001 to 2004 among 165 patients ages 67 to 100 with moderate to severe forms of the disease. The findings underscore the need for personalized drug therapies, an Alzheimer's specialist said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ